We also investigated whether OATP1B1 (c.388 A>G, c.521T>C) and OATP1B3 (c.334 T>G, c.699 G>A) were associated with the side effects of OATP as a carrier in hepatitis C patients. This evidence concerns the gene SLCO1B1 and hepatitis C virus infection.